| 📋 Article Summary — Hexavalent Chromium in Australian Workplaces | |
|---|---|
| Entity | Hexavalent chromium Cr(VI), Safe Work Australia, IARC |
| Article Type | Technical / Hazard Guide |
| Target Audience | Electroplating workers, welders, painters using chromate primers, HSE managers |
| Key Entities | Safe Work Australia, AIOH, IARC, NATA laboratories |
| Regulations | WHS Regulations 2017, Safe Work Australia WES document |
| Key Fact 1 | Cr(VI) is a Group 1 IARC carcinogen — confirmed human lung carcinogen from inhalation exposure |
| Key Fact 2 | Australian WES-TWA for Cr(VI): 0.05 mg/m³ (as Cr) — a very low value reflecting carcinogen status |
| Key Fact 3 | Chromate conversion coatings and stainless steel welding are the most common industrial sources of Cr(VI) exposure |
| What This Covers | Cr(VI) sources, health effects, WES, monitoring, LEV design, RPE, biological monitoring |
| What This Does Not Cover | Trivalent chromium toxicity, chromium in stainless steel alloys |
| Primary CTA | Contact Anitech for Cr(VI) exposure monitoring and controls assessment |
| Read Time | 9 min |
What Is Hexavalent Chromium?
Chromium exists in several oxidation states. Trivalent chromium Cr(III) is an essential trace nutrient at very low concentrations. Hexavalent chromium Cr(VI), however, is a highly toxic and carcinogenic form produced in industrial processes. The critical difference is chemical — Cr(VI) compounds are powerful oxidisers capable of penetrating cell membranes and damaging DNA, while Cr(III) is largely excluded from cells and eliminated efficiently.
Cr(VI) is generated or used in several Australian industries:
- Hard and decorative chrome electroplating: Chrome plating baths contain chromic acid (H₂CrO₄), generating highly toxic mists and fumes
- Stainless steel welding: Welding of stainless steel containing chromium alloy generates Cr(VI) in the fume — sometimes at concentrations many times the WES
- Chromate primers and coatings: Zinc chromate and strontium chromate anti-corrosion primers used in aerospace, defence, and heavy engineering
- Chromate conversion coating (passivation): Chromate treatment of aluminium and zinc surfaces for corrosion protection
- Pigment manufacture: Chrome yellow (lead chromate) and other chromium pigments
Health Effects of Cr(VI) Exposure
Cancer
Cr(VI) is classified as a Group 1 human carcinogen by IARC based on sufficient evidence of lung cancer in workers in chromate production, chrome plating, and chromate pigment industries. Lung cancer risk is elevated at cumulative doses well within the range of occupational exposure. There is also evidence of nasal and sinonasal cancer risk. The mechanism involves Cr(VI) crossing cell membranes, undergoing intracellular reduction to Cr(III), and creating Cr-DNA adducts that cause mutations.
Nasal Septum Perforation and Ulceration
Chrome platers have historically developed chrome ulcers (chrome holes) — painless perforations of the nasal septum from chronic chromic acid mist exposure. These lesions are characteristic markers of significant Cr(VI) exposure. They do not heal and serve as indicators of inadequate historical exposure control.
Dermatitis and Skin Sensitisation
Cr(VI) is a potent skin sensitiser. Chromate dermatitis is one of the most common causes of occupational allergic contact dermatitis in Australia. Once sensitised, workers react to very low skin concentrations of Cr(VI) — including from cement (which contains small amounts of Cr(VI) from the raw materials). The reaction manifests as a chronic, intensely pruritic eczematous rash on the hands and forearms.
Respiratory Sensitisation and Occupational Asthma
Cr(VI) can cause occupational asthma in exposed workers. The mechanism involves both IgE-mediated sensitisation and non-immunological irritant effects on the airways.
Monitoring and Assessment
Air monitoring for Cr(VI) requires sampling onto mixed cellulose ester (MCE) filter membranes using personal or area sampling pumps, followed by NATA-accredited laboratory analysis by ion chromatography or colorimetric methods (diphenylcarbazide method). The very low WES (0.05 mg/m³ as Cr) requires sensitive analytical methods and careful field sampling technique.
Biological monitoring using urinary chromium is available and provides a measure of total Cr(VI) body burden integrating both inhalation and skin absorption routes. Urinary chromium is measured at the end of shift and end of working week.
Controls for Cr(VI) Exposure
Engineering controls are the primary strategy for Cr(VI) management. For chrome plating, LEV with appropriate capture velocity directly at the plating bath surface is essential — typically achieved with push-pull ventilation systems that move clean air across the tank surface to a plenum exhaust. Suppression agents (wetting agents) added to plating baths reduce mist generation.
For stainless steel welding, LEV capture hoods positioned close to the welding arc, combined with water-cooled weld torches to reduce fume generation, are the preferred engineering approach. Where LEV is impractical (e.g., on-site welding), powered air-purifying respirators (PAPR) with P3 filters are required.
Frequently Asked Questions
Does welding mild steel generate Cr(VI)?
Mild steel (low-alloy carbon steel) contains negligible chromium and welding does not generate significant Cr(VI). Cr(VI) is primarily a concern when welding stainless steel, chrome-moly alloys, or when welding metal coated with chromate primer. Always check the composition of the base metal and any coatings before assuming Cr(VI) is absent.
Is there a safe level of Cr(VI) exposure?
As a carcinogen with no demonstrated safe threshold, the goal should be to minimise Cr(VI) exposure to as low as reasonably practicable (ALARP) — not merely to comply with the WES. The WES represents a compromise between protection and practicability, not a “safe” threshold.